Literature DB >> 29159704

Neuroimmune Regulation of JC Virus by Intracellular and Extracellular Agnoprotein.

Michael Craigie1, Stephanie Cicalese1, Ilker Kudret Sariyer2.   

Abstract

JC virus (JCV) is a human polyomavirus and the etiologic agent of the demyelinating disease progressive multifocal leukoencephalopathy (PML). PML is observed in patients with underlying immunocompromising conditions, suggesting that neuro-immune interactions between peripheral immune cells and neuro-glia play an important role in controlling viral reactivation in the brain. There is little known about the immunobiology of JCV reactivation in glial cells and the role of immune, glial, and viral players in this regulation. We have previously showed that agnoprotein, a small JCV regulatory protein, is released from infected cells and internalized by neighboring bystander cells. Here we have investigated the possible role of extracellular and intracellular agnoprotein in the neuroimmune response to JC virus. Our findings suggest that glial cells exposed to agnoprotein secrete significantly less GM-CSF, which is mediated by agnoprotein induced suppression of GM-CSF transcription. Likewise, monocytes treated with agnoprotein showed altered differentiation and maturation. In addition, monocytes and microglial cells exposed to agnoprotein showed a significant reduction in their phagocytic activities. Moreover, when an in vitro blood-brain barrier model was used, agnoprotein treatment resulted in decreased monocyte migration through the endothelial cell layer in response to activated astrocytes. All together, these results have revealed a novel immunomodulatory function of agnoprotein during JCV infection within theCNS and open a new avenue of research to better understand the mechanisms associated with JCV reactivation in patients who are at risk of developing PML.

Entities:  

Keywords:  Agnoprotein; Blood-brain barrier; Differentiation; Gm-CSF; Immunomodulation; JC virus; Migration; Monocytes; Neuroinflammation; PML

Mesh:

Substances:

Year:  2017        PMID: 29159704      PMCID: PMC5930035          DOI: 10.1007/s11481-017-9770-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  48 in total

1.  Purified JC virus T and T' proteins differentially interact with the retinoblastoma family of tumor suppressor proteins.

Authors:  B Bollag; C Prins; E L Snyder; R J Frisque
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

2.  JC virus infection in cells from lymphoid tissue.

Authors:  M C Monaco; J Shin; E O Major
Journal:  Dev Biol Stand       Date:  1998

Review 3.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.

Authors:  Francisco-Javier San-Andrés; Rafael Rubio; Jesús Castilla; Federico Pulido; Guillermo Palao; Inmaculada de Pedro; José-Ramón Costa; Angel del Palacio
Journal:  Clin Infect Dis       Date:  2003-04-14       Impact factor: 9.079

5.  Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.

Authors:  P Cinque; L Vago; M Mengozzi; V Torri; D Ceresa; E Vicenzi; P Transidico; A Vagani; S Sozzani; A Mantovani; A Lazzarin; G Poli
Journal:  AIDS       Date:  1998-07-30       Impact factor: 4.177

Review 6.  Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.

Authors:  Igor J Koralnik
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

7.  Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain.

Authors:  Yuki Okada; Hirofumi Sawa; Shuichi Endo; Yasuko Orba; Takashi Umemura; Hiroshi Nishihara; Alexandru C Stan; Shinya Tanaka; Hidehiro Takahashi; Kazuo Nagashima
Journal:  Acta Neuropathol       Date:  2002-05-24       Impact factor: 17.088

8.  Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content.

Authors:  Ilker K Sariyer; Abdullah S Saribas; Martyn K White; Mahmut Safak
Journal:  Virol J       Date:  2011-05-24       Impact factor: 4.099

9.  JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant.

Authors:  Xin Dang; Christian Wüthrich; Jennifer Gordon; Hirofumi Sawa; Igor J Koralnik
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

Review 10.  Subversion of the Immune Response by Rabies Virus.

Authors:  Terence P Scott; Louis H Nel
Journal:  Viruses       Date:  2016-08-19       Impact factor: 5.048

View more
  6 in total

1.  A comprehensive proteomics analysis of JC virus Agnoprotein-interacting proteins: Agnoprotein primarily targets the host proteins with coiled-coil motifs.

Authors:  A Sami Saribas; Prasun K Datta; Mahmut Safak
Journal:  Virology       Date:  2019-10-20       Impact factor: 3.616

Review 2.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

3.  Human neurotropic polyomavirus, JC virus, agnoprotein targets mitochondrion and modulates its functions.

Authors:  Reshu Saxena; Sami Saribas; Pooja Jadiya; Dhanendra Tomar; Rafal Kaminski; John W Elrod; Mahmut Safak
Journal:  Virology       Date:  2020-11-25       Impact factor: 3.616

4.  Modulation of OPRM1 Alternative Splicing by Morphine and HIV-1 Nef.

Authors:  Martina Donadoni; Wenfei Huang; Shadan S Yarandi; Tricia H Burdo; Sulie L Chang; Ilker K Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2021-08-21       Impact factor: 4.147

Review 5.  Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.

Authors:  Abigail L Atkinson; Walter J Atwood
Journal:  Viruses       Date:  2020-09-01       Impact factor: 5.048

Review 6.  Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Authors:  Siobhan Gargan; Nigel J Stevenson
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.